Information  X 
Enter a valid email address

Standard Life Aberdn (SLA)

  Print      Mail a friend

Thursday 21 May, 2020

Standard Life Aberdn

Transaction in Own Shares

RNS Number : 5380N
Standard Life Aberdeen plc
21 May 2020
 

Transactions in own shares

 

Standard Life Aberdeen plc (the Company) announces today it has purchased the following number of its ordinary shares of 1361/63 pence each on the London Stock Exchange through J.P. Morgan Securities plc.

 

Description of shares:

 

Ordinary Shares

 

Date of purchase:

 

20 May 2020

Number of ordinary shares purchased:

 

6,246

Lowest price per share:

 

227.70

Highest price per share:

 

228.90

Trading venue:

 

XLON

Aggregate volume per date per trading venue:

 

6,246

Weighted average price per day per trading venue:

 

228.6452

The Company intends to cancel the purchased shares.

 

LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90

 

Individual Transactions

 

Transaction Date and Time

Volume

Price (GBp)

Platform

Transaction Reference Number

20-May-2020 08:36:14

561

228.9000

XLON

11002110000002536-E01lZsFbRGCi20200520

20-May-2020 08:54:40

722

228.7000

XLON

01002010000027480-E01lZsFbRjSV20200520

20-May-2020 08:55:12

1083

228.3000

XLON

11002110000027104-E01lZsFbRkQq20200520

20-May-2020 08:56:42

260

227.7000

XLON

11002110000028469-E01lZsFbRmhX20200520

20-May-2020 08:56:42

357

227.7000

XLON

11002110000028469-E01lZsFbRmhV20200520

20-May-2020 09:12:42

566

228.8000

XLON

11002110000036202-E01lZsFbS9vO20200520

20-May-2020 10:36:33

936

228.9000

XLON

01002010000062245-E01lZsFbU52Y20200520

20-May-2020 10:36:33

646

228.9000

XLON

11002110000061358-E01lZsFbU52U20200520

20-May-2020 10:36:33

269

228.9000

XLON

11002110000061358-E01lZsFbU52W20200520

20-May-2020 10:41:46

846

228.9000

XLON

01002010000075912-E01lZsFbUBJM20200520

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSQBLFLBELBBBD

a d v e r t i s e m e n t